Graphite Bio, Inc.(GRPH),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community - To The Moon

At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.

Close

GRPH Graphite Bio, Inc.

Post-Market Trading 12-26 16:38:43 EST

15.05

+0.00

0.00%

High15.05	Low15.05	Vol0.00
Open15.05	D1 Closing15.05	Amplitude0.00%
Mkt Cap876.47M	Tradable Cap251.01M	Total Shares58.24M
T/O1.03M	T/O Rate0.00%	Tradable Shares16.68M
P/B--	ROE--	EPS0.00
52wk High--	52wk Low--	P/E--
Dividend--	Div.Yield--	ROA--

{"stockData":{"symbol":"GRPH","market":"US","secType":"STK","nameCN":"Graphite Bio, Inc.","latestPrice":15.05,"timestamp":1711051200000,"preClose":15.05,"halted":8,"volume":0,"delay":0,"floatShares":16678630,"shares":58236926,"eps":-2.186278,"marketStatus":"Post-Market Trading","change":0,"latestTime":"12-26 16:38:43 EST","open":15.05,"high":15.05,"low":15.05,"amount":1032198.4924146,"amplitude":0,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-2.186278,"tradingStatus":3,"nextMarketStatus":{"tag":"Closed","tradingStatus":0,"beginTime":1735261200000},"marketStatusCode":4,"symbolChange":{"newSymbol":"LENZ","executeDate":"2024-03-22"},"adr":0,"listingDate":1624593600000,"exchange":"NASDAQ","adjPreClose":15.05,"volumeRatio":0},"requestUrl":"/m/hq/s/GRPH","defaultTab":"news","newsList":[{"id":"2421049860","title":"Graphite Bio’s Strategic Merger and Rebranding to LENZ Therapeutics","url":"https://stock-news.laohu8.com/highlight/detail?id=2421049860","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2421049860?lang=en_us&edition=fundamental","pubTime":"2024-03-22 18:12","pubTimestamp":1711102364,"startTime":"0","endTime":"0","summary":"The latest announcement is out from Graphite Bio (GRPH). On March 14, 2024, Graphite’s stockholders approved significant decisions, including issui...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/graphite-bios-strategic-merger-and-rebranding-to-lenz-therapeutics?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/graphite-bios-strategic-merger-and-rebranding-to-lenz-therapeutics?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","BK4539","GRPH"],"gpt_icon":0},{"id":"2421070576","title":"BRIEF-LENZ Therapeutics Announces Completion of Merger with Graphite Bio","url":"https://stock-news.laohu8.com/highlight/detail?id=2421070576","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2421070576?lang=en_us&edition=fundamental","pubTime":"2024-03-22 05:17","pubTimestamp":1711055826,"startTime":"0","endTime":"0","summary":"March 21 (Reuters) - Graphite Bio Inc   :   * LENZ THERAPEUTICS:  APPOINTED DAN CHEVALLARD AS CFO , EFFECTIVE MARCH 21, 2024Source text for Eikon:    Further company coverage:    ((Reuters.Briefs@thomsonreuters.com;))","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["GRPH","BK4539","BK4202","BK4139","AS"],"gpt_icon":0},{"id":"2421074946","title":"Press Release: LENZ Therapeutics Announces Completion of Merger with Graphite Bio and Provides Update on Recent Clinical and Corporate Progress","url":"https://stock-news.laohu8.com/highlight/detail?id=2421074946","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2421074946?lang=en_us&edition=fundamental","pubTime":"2024-03-22 04:30","pubTimestamp":1711053000,"startTime":"0","endTime":"0","summary":"LENZ Therapeutics Announces Completion of Merger with Graphite Bio and Provides Update on Recent Clinical and Corporate Progress. -- LENZ Therapeutics to debut on Nasdaq under the ticker symbol \"LENZ\" as a publicly traded company advancing late clinical-stage assets for the treatment of presbyopia --. Previously, both LNZ100 and LNZ101 have demonstrated rapid onset and long duration of near vision improvement as well as an ability to be used across a wide age range of presbyopes with a broad refractive range while avoiding blurry distance vision. In the positive Phase 2 INSIGHT trial , both LZN100 and LNZ101 achieved their primary endpoint of three-lines or greater near vision improvement without losing one or more lines in distance vision at one hour post-treatment, with 71%  and 56%  of treated patients achieving th","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SG9999002604.SGD","BK4539","SG9999013460.SGD","BK4085","BK4503","LU0532188223.SGD","PRGS","IE00BD4GTT62.SGD","D","BK4554","SG9999004360.SGD","BK4566","BK4535","LU0048573645.USD","LU0251143029.SGD","BK4551","SGXZ58947870.SGD","IE0034224299.USD","LU2065732104.USD","SG9999002620.SGD","INAQU","SG9999002679.SGD","IE00BD4GTW91.USD","SG9999014484.SGD","SG9999002406.SGD","BK4548","GRPH","IE00BMG7P926.USD","SG9999006266.SGD","BK4097","SG9999013478.USD","IE00BD4GTV84.USD","SG9999002414.USD","BK4588","LU0210637038.USD","SG9999014492.USD","IE00BMG7P694.USD","SG9999005177.SGD","BK4585","IE00BMG7P587.USD","BK4139","BK4581","NQmain","SE","SG9999001135.SGD","SG9999013486.USD","BK4208"],"gpt_icon":0},{"id":"2421041781","title":"11 Stocks that Paid Special Dividends in 2024","url":"https://stock-news.laohu8.com/highlight/detail?id=2421041781","media":"Insider Monkey","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2421041781?lang=en_us&edition=fundamental","pubTime":"2024-03-21 22:09","pubTimestamp":1711030194,"startTime":"0","endTime":"0","summary":"In this article, we discuss 11 stocks that paid special dividends in 2024. You can skip our detailed analysis of dividend stocks and their performance over the years, and go directly to read 5 Stocks that Paid Special Dividends in 2024.As mentioned earlier, the number of special dividends distributed by US companies has varied over the years. In 2018, there were 48 instances of such dividends paid by S&P 100 companies, followed by a slight decrease to 43 in 2019, according to data by S&P Global Market Intelligen","market":"us","thumbnail":"https://s.yimg.com/uu/api/res/1.2/YBQoT4eTm3PgBJ.l9nUz9Q--~B/aD0xMjgwO3c9MTkyMDthcHBpZD15dGFjaHlvbg--/https://media.zenfs.com/en/insidermonkey.com/d940df2e829c17173d31638432990d3d","type":0,"news_type":0,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/YBQoT4eTm3PgBJ.l9nUz9Q--~B/aD0xMjgwO3c9MTkyMDthcHBpZD15dGFjaHlvbg--/https://media.zenfs.com/en/insidermonkey.com/d940df2e829c17173d31638432990d3d"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/11-stocks-paid-special-dividends-140954643.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["IE00BFSS8Q28.SGD","LU0170899867.USD","LU1571399168.USD","LU0868494617.USD","BK4139","IE00BWXC8680.SGD","QQQ","RWAY","BK4581","LU0061475181.USD","LU0234572021.USD","LU0061474705.USD","BK4587","TQQQ","BK4548","LU0053666078.USD","BK4579","IE0004445239.USD","QID","CL","IE00BKDWB100.SGD","PEP","LU0109391861.USD","NYSE","QLD","SG9999001440.SGD","BK4576","MSFT","SIGA",".IXIC","LIAN","BK4592","NQmain","MNQmain","SQQQ","BK4588","GB00B4LPDJ14.GBP","LU0082616367.USD","PG","PSQ","CLRO","GRPH","BK4577","LU2242646821.SGD","GB00B4QBRK32.GBP","EM","BK4585","LU0080751232.USD","BK4018","LU1280957306.USD"],"gpt_icon":0},{"id":"2420786889","title":"Graphite Bio Approves Merger, Name Change, and Stock Split","url":"https://stock-news.laohu8.com/highlight/detail?id=2420786889","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2420786889?lang=en_us&edition=fundamental","pubTime":"2024-03-20 04:43","pubTimestamp":1710881009,"startTime":"0","endTime":"0","summary":"Graphite Bio (GRPH) has shared an update. Graphite’s stockholders have given the green light to a transformative merger, approving a reverse stock ...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/graphite-bio-approves-merger-name-change-and-stock-split?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/graphite-bio-approves-merger-name-change-and-stock-split?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","BK4539","GRPH"],"gpt_icon":0},{"id":"2420822073","title":"Graphite Bio, SCWorx, Acurx Pharmaceuticals among healthcare movers","url":"https://stock-news.laohu8.com/highlight/detail?id=2420822073","media":"seekingalpha","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2420822073?lang=en_us&edition=fundamental","pubTime":"2024-03-19 22:00","pubTimestamp":1710856851,"startTime":"0","endTime":"0","summary":"Gainers: Fusion Pharmaceuticals  +97%. SCWorx  +68%. Enveric Biosciences  +43%. Hoth Therapeutics  +23%. Enliven Therapeutics  +20%.  Losers: Graphite Bio  -13%. Adverum Biotechnologies  -19%. Lantern Pharma  -18%. Acurx Pharmaceuticals  -16%. Eyenovia  -14%.  S&P 500 Health Care Sector -0.02% to 1689.96. Health Care Equipment & Services -0.1% to 1973.91. Pharmaceuticals, Biotechnology & Life Science which contributes 58% to index is +0.02% to 1378.25.  More on Health Care Select Sector SPDR  XLV: Low-Cost Exposure To A Defensive Sector, While Achieving Strong Performance Healthcare In 2024: Navigating The Biopharma Bull Run XLV Likely Back To Outperforming Johnson & Johnson, Boston Scientific least shorted stocks in S&P 500 healthcare sector for Feb-end Waters, Moderna most shorted stocks in S&P 500 health sector till Jan-end","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://seekingalpha.com/news/4081116-graphite-bio-scworx-acurx-pharmaceuticals-among-healthcare-movers","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"seekingalpha","symbols":["BK4139","ELVN","SDS","SPY","EYEN","IVV",".SPX","ENVB","BK4563","SH","UPRO","HOTH","BK4007","BK4550","FUSN","BK4581","BK4534","BK4539","BK4504","BK4167","ADVM","BK4588","ACXP","SSO","LTRN","SPXU","BK4585","OEX","ESmain","OEF","GRPH","WORX","BK4559"],"gpt_icon":0},{"id":"2419381661","title":"AVLX, SGH and ETNB are among pre market losers","url":"https://stock-news.laohu8.com/highlight/detail?id=2419381661","media":"seekingalpha","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2419381661?lang=en_us&edition=fundamental","pubTime":"2024-03-16 04:48","pubTimestamp":1710535713,"startTime":"0","endTime":"0","summary":"Gainers:89bio (ETNB) +5%.Black Diamond Therapeutics (BDTX) +5%.Anavex Life Sciences (AVXL) +3%.iHeartMedia (IHRT) +2%.SMART Global Holdings (SGH) +2%.Losers:CERo Therapeutics Holdings, (CERO) -5%.Mersana Therapeutics (MRSN) -5%.Castle Biosciences (CSTL) -5%.Graphite (GRPH) -4%.Qurate Retail (QRTEB) -3%.","market":"nz","thumbnail":"https://static.seekingalpha.com/cdn/s3/uploads/getty_images/522334235/image_522334235.jpg","type":0,"news_type":0,"thumbnails":["https://static.seekingalpha.com/cdn/s3/uploads/getty_images/522334235/image_522334235.jpg"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://seekingalpha.com/news/4080194-avlx-sgh-and-etnb-are-among-pre-market-losers","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"seekingalpha_hot_news","symbols":["BK4539","MRSN","AVXL","BK7120","CERO","GRPH","IHRT","ETNB","BK4122","BK4139","BK4196","BK4563","SGH.AU","BK4220","BK4141","SGH","BK4125","BDTX","QRTEB","BK4585","CSTL"],"gpt_icon":0},{"id":"2419907809","title":"VERI, STI and VERB among mid-day movers","url":"https://stock-news.laohu8.com/highlight/detail?id=2419907809","media":"seekingalpha","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2419907809?lang=en_us&edition=fundamental","pubTime":"2024-03-16 00:52","pubTimestamp":1710521525,"startTime":"0","endTime":"0","summary":"Gainers: Verb Technology Company  +437%. Geron Corp.  +72%. Better Therapeutics  +72%. Solidion Technology  +61%. Cardlytics  +55%. Hcm Acquisition Corp  +48%. Canoo  +47%. Graphite Bio  +31%. Veritone  +24%. Laird Superfood  +23%.   Losers: C3is  -63%. Groupon  -31%. SELLAS Life Sciences Group  -29%. Lucy Scientific Discovery  -26%. Immuneering Corp  -26%. Altus Power  -26%. Anywhere Real Estate  -20%. Biofrontera  -18%. Psyence Biomedical Ltd.  -19%. Urgent.ly  -18%.   More on Mid-day movers & stocks.  Veritone, Inc.  Q4 2023 Earnings Call Transcript Solidion Technology climbs 10% on $3.85M private placement Veritone Non-GAAP EPS of -$0.16 in-line, revenue of $34.2M beats by $0.4M Financial information for SunTrust Banks Seeking Alpha’s Quant Rating on Verb Technology","market":"hk","thumbnail":"https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1215119911/image_1215119911.jpg","type":0,"news_type":0,"thumbnails":["https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1215119911/image_1215119911.jpg"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://seekingalpha.com/news/4080080-veri-sti-and-verb-among-mid-day-movers","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"seekingalpha_hot_news","symbols":["STI","BK4021","SLS.AU","BK4563","GOEV","STI.SI","HCMA","AMPS","BK4099","ULY","BK4023","BK4079","SLS","GRPN","CDLX","BK4007","HOUS","BK4133","BK4009","BK4139","BK4579","BK4122","IMRX","LSDI","CISS","BK7104","BK4167","GRPH","VERB","BFRI","BTTX","PBM","BK4212","BK4220","LSF","BK4539","VERI","LSF.AU","BK4096","BK4543","GERN"],"gpt_icon":0},{"id":"2419597755","title":"Geron, Graphite Bio, Immuneering among healthcare movers","url":"https://stock-news.laohu8.com/highlight/detail?id=2419597755","media":"seekingalpha","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2419597755?lang=en_us&edition=fundamental","pubTime":"2024-03-15 22:00","pubTimestamp":1710511213,"startTime":"0","endTime":"0","summary":"Gainers: Better Therapeutics  +112%. Geron  +70%. Graphite Bio  +24%. Madrigal Pharmaceuticals  +20%. Spectral AI  +15%.  Losers: SELLAS Life Sciences Group  -32%. Lucy Scientific Discovery  -32%. Immuneering  -24%. Biofrontera  -11%. Eton Pharmaceuticals  -11%.   S&P 500 Health Care Sector -0.46% to 1688.46. Health Care Equipment & Services -0.67% to 1964.66. Pharmaceuticals, Biotechnology & Life Science which contributes 58% to index is -0.3% to 1380.82.  More on Health Care Select Sector SPDR  XLV: Low-Cost Exposure To A Defensive Sector, While Achieving Strong Performance Healthcare In 2024: Navigating The Biopharma Bull Run XLV Likely Back To Outperforming Johnson & Johnson, Boston Scientific least shorted stocks in S&P 500 healthcare sector for Feb-end Waters, Moderna most shorted stocks in S&P 500 health sector till Jan-end","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://seekingalpha.com/news/4079970-geron-graphite-bio-immuneering-among-healthcare-movers","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"seekingalpha_hot_news","symbols":["BK4139","GERN","SLS","BK4563","BK4082","GRPH","SSO","MDGL","OEX","SLS.AU","UPRO","BK4581",".SPX","BK4588","BK4539","BFRI","BK4550","IVV","BK4167","BK4504","SPY","MDAI","BK4559","ETON","ESmain","BTTX","BK4534","OEF","SH","SDS","IMRX","BK4585","SPXU","BK7104","LSDI","BK4007"],"gpt_icon":0},{"id":"2418635018","title":"ETRN, CRDF and KC are among pre market gainers","url":"https://stock-news.laohu8.com/highlight/detail?id=2418635018","media":"seekingalpha","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2418635018?lang=en_us&edition=fundamental","pubTime":"2024-03-11 21:30","pubTimestamp":1710163853,"startTime":"0","endTime":"0","summary":"Kidpik  +281%. L.S. Starrett  +59% Enters Into a Merger Agreement With MiddleGround Capital to Become Private Company.  TC BioPharm  +57%. Unusual Machines  +34%. Auddia  +27%. Sonnet BioTherapeutics  +20% Announces Early Safety Data from the Company’s Phase 1b/2a Clinical Trial of SON-080 in Chemotherapy-Induced Peripheral Neuropathy  Met the Study’s Initial Pre-Specified Objective.  Mesoblast  +19% Crypto-linked stocks, MESO and more  Graphite  +16%. 180 Life Sciences  +13%. NuScale Power Corporation  +15% to Participate in March and April 2024 Investor Conferences.  AirNet Technology  +15% Announces Changes in the Board of Directors  Mawson Infrastructure Group  +14%. GDS Holdings Limited  +14%. Amplify Energy  +13% oil sheen not related to its operations.  Kingsoft Cloud Holdings  +12%. Lexeo Therapeutics  +10% Reports Fourth Quarter and Full Year 2023 Financial Results and Operational Highlights.  Microstrategy  +10%. Marpai  +9%. Revelation Biosciences  +9%. Cardiff Oncology  +9%","market":"nz","thumbnail":"https://static.seekingalpha.com/cdn/s3/uploads/getty_images/522334235/image_522334235.jpg","type":0,"news_type":0,"thumbnails":["https://static.seekingalpha.com/cdn/s3/uploads/getty_images/522334235/image_522334235.jpg"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://seekingalpha.com/news/4077980-etrn-crdf-and-kc-are-among-pre-market-gainers","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"seekingalpha_hot_news","symbols":["BK4539","BK4144","MRAI","MSTR","AUUD","BK4116","GRPH","TCBP","UMAC","ATNF","MESO","BK4213","BK4023","BK4122","BK4139","GXAI","KC","MSTR.AU","SMR","SMR.AU","BK7083","BK4563","MIGI","BK4531","SCX","BK4204","HSAI","BK4157","BK4161","BK4595","CRDF","LXEO","BK4094","ANTE","AMPY","GDS","BK4505","BK4182","LXEH","ETRN","BK4173","BK4085","SONN","BK7129","BK4009","BK4585","BK4588","REVB","BK4526","PIK"],"gpt_icon":0},{"id":"2418012053","title":"Stocks to Watch: Graphite Bio, Revance Therapeutics","url":"https://stock-news.laohu8.com/highlight/detail?id=2418012053","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2418012053?lang=en_us&edition=fundamental","pubTime":"2024-03-09 07:54","pubTimestamp":1709942040,"startTime":"0","endTime":"0","summary":"Graphite Bio on Friday said it would pay a special dividend tied to its merger with Lenz Therapeutics. Shares of the biotechnology company climbed 10% to $3.46 in after-hours trading.Revance Therapeutics said its chief executive bought additional shares in the company. Shares of the biotechnology company rose 2.7% to $6.17 in after-hours trading.","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4539","BK4007","LU0053671581.USD","GRPH","RVNC","BK4585","BK4139","BK4588"],"gpt_icon":0},{"id":"2418829014","title":"Graphite Bio Shares Pop 14% On Special Dividend","url":"https://stock-news.laohu8.com/highlight/detail?id=2418829014","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2418829014?lang=en_us&edition=fundamental","pubTime":"2024-03-09 07:15","pubTimestamp":1709939700,"startTime":"0","endTime":"0","summary":"Shares of Graphite Bio popped Friday after the company said it would pay a special dividend connected with its merger.The stock was up 14% to $3.59 in after-hours trading, following a 0.3% rise at Friday's close. Shares are up 20% this year as of the close.The South San Francisco, Calif.-based company said it expected the special dividend to be $1.03 a share.The exact amount of the dividend will be set after certain cash deductions, but the total value paid will not exceed $60 million, Graphite said.The dividend is linked to Graphite's previously announced merger with Lenz Therapeutics. The company said it expects the deal to close March 21 following a shareholder vote March 14.The companies said they were targeting a deal close in the first quarter of 2024 when they announced the tie-up in November.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4539","GRPH","BK4139"],"gpt_icon":0},{"id":"2418019501","title":"Graphite Bio announces $1.03 per share special dividend By Investing.com","url":"https://stock-news.laohu8.com/highlight/detail?id=2418019501","media":"Investing.com","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2418019501?lang=en_us&edition=fundamental","pubTime":"2024-03-09 06:35","pubTimestamp":1709937332,"startTime":"0","endTime":"0","summary":"Graphite Bio announces $1.03 per share special dividend By Investing.com","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"redbox_crawler","url":"https://news.google.com/rss/articles/CBMic2h0dHBzOi8vd3d3LmludmVzdGluZy5jb20vbmV3cy9zdG9jay1tYXJrZXQtbmV3cy9ncmFwaGl0ZS1iaW8tYW5ub3VuY2VzLTEwMy1wZXItc2hhcmUtc3BlY2lhbC1kaXZpZGVuZC05M0NILTMzMzEyNTfSAQA?oc=5","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://news.google.com/rss/articles/CBMic2h0dHBzOi8vd3d3LmludmVzdGluZy5jb20vbmV3cy9zdG9jay1tYXJrZXQtbmV3cy9ncmFwaGl0ZS1iaW8tYW5ub3VuY2VzLTEwMy1wZXItc2hhcmUtc3BlY2lhbC1kaXZpZGVuZC05M0NILTMzMzEyNTfSAQA?oc=5","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"redbox_crawler","symbols":["BK4539","GRPH","BK4139"],"gpt_icon":0},{"id":"2418301601","title":"Graphite Bio Announces Special Dividend Amid Lenz Merger","url":"https://stock-news.laohu8.com/highlight/detail?id=2418301601","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2418301601?lang=en_us&edition=fundamental","pubTime":"2024-03-09 06:22","pubTimestamp":1709936551,"startTime":"0","endTime":"0","summary":"Graphite Bio (GRPH) has issued an announcement. Graphite Bio, Inc. has announced a special cash dividend for stockholders in light of its upcoming ...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/graphite-bio-announces-special-dividend-amid-lenz-merger?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/graphite-bio-announces-special-dividend-amid-lenz-merger?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4539","GRPH","BK4139"],"gpt_icon":0},{"id":"2418016984","title":"Graphite Bio to Pay Special Dividend Linked to Lenz Therapeutics Merger","url":"https://stock-news.laohu8.com/highlight/detail?id=2418016984","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2418016984?lang=en_us&edition=fundamental","pubTime":"2024-03-09 06:16","pubTimestamp":1709936160,"startTime":"0","endTime":"0","summary":"Graphite Bio will pay a special dividend connected to its merger with Lenz Therapeutics.The South San Francisco, Calif.-based gene editing company said Friday it estimated the special dividend will be $1.03 a share.The total value of the special dividend won't exceed $60 million, subject to certain adjustments in the merger agreement, according to Graphite Bio. The exact amount of the dividend will be determined after deducting certain cash amounts as outlined in the merger agreement.The payment of the dividend is conditioned on the merger closing. Graphite Bio shareholders will vote on the deal at a March 14 meeting, with closing expected March 21.Graphite Bio and Lenz said in November they planned to merge in an all-stock deal.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","GRPH","BK4539"],"gpt_icon":0},{"id":"2418150620","title":"BRIEF-Graphite Bio Inc Special Dividend Estimated To Be $1.03 Per Share","url":"https://stock-news.laohu8.com/highlight/detail?id=2418150620","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2418150620?lang=en_us&edition=fundamental","pubTime":"2024-03-09 06:07","pubTimestamp":1709935622,"startTime":"0","endTime":"0","summary":"March 8 (Reuters) - Graphite Bio Inc   :   * GRAPHITE BIO INC: SPECIAL DIVIDEND ESTIMATED TO BE $1.03 PER SHARE   * GRAPHITE BIO INC:  DECLARES SPECIAL DIVIDEND ESTIMATED TO BE $1.03 PER SHARESource text for Eikon:    Further company coverage:","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","GRPH","BK4539"],"gpt_icon":0},{"id":"2418812156","title":"Graphite Bio declares special $1.03 dividend","url":"https://stock-news.laohu8.com/highlight/detail?id=2418812156","media":"seekingalpha","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2418812156?lang=en_us&edition=fundamental","pubTime":"2024-03-09 06:04","pubTimestamp":1709935473,"startTime":"0","endTime":"0","summary":"Payable March 21; for shareholders of record March 18; ex-div March 15.See GRPH Dividend Scorecard, Yield Chart, & Dividend Growth.More on Graphite Bio  Graphite Bio: Reverse Merger Leading Into Big Special Dividend And Q2 Phase 3 Trial Seeking Alpha’s Quant Rating on Graphite Bio Historical earnings data for Graphite Bio Financial information for Graphite Bio","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://seekingalpha.com/news/4077779-graphite-bio-inc-declares-1_03-dividend","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"seekingalpha","symbols":["BK4539","BK4139","GRPH"],"gpt_icon":0},{"id":"2418901506","title":"Graphite Bio Declares Special Dividend In Connection with Proposed Merger with Lenz Therapeutics","url":"https://stock-news.laohu8.com/highlight/detail?id=2418901506","media":"StreetInsider","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2418901506?lang=en_us&edition=fundamental","pubTime":"2024-03-09 06:00","pubTimestamp":1709935200,"startTime":"0","endTime":"0","summary":"Payment of special dividend conditioned upon closing of merger. Graphite Bio, Inc.   today announced that its Board of Directors has declared a special dividend in connection with the previously announced merger  with Lenz Therapeutics, Inc.  pursuant to the Agreement and Plan of Merger, dated November 14, 2023 .LENZ is a late-stage biopharmaceutical company focused on developing and commercializing innovative therapies to improve vision. Its product candidates, LNZ100 and LNZ101, are preservative-free, single-use, once-daily, aceclidine-based eye drops currently in Phase 3 clinical trials for the treatment of presbyopia. Presbyopia impacts an estimated 1.8 billion people globally and 128 million people in the United States. LENZ is headquartered in San Diego, California, and is backed by venture capital investors, including Versant Ventures, RA Capital Management, Alpha Wave Global, Point72, Samsara BioCapital, Sectoral Asset Management and RTW Investments. For more information, visit","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.streetinsider.com/dr/news.php?id=22908245","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"highlight_streetinsider","symbols":["BK4139","BK4539","GRPH"],"gpt_icon":0},{"id":"2416539640","title":"Kuehn Law Encourages FIXX, SCTL, EVRI, and GRPH Investors to Contact Law Firm","url":"https://stock-news.laohu8.com/highlight/detail?id=2416539640","media":"StreetInsider","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2416539640?lang=en_us&edition=fundamental","pubTime":"2024-03-01 23:49","pubTimestamp":1709308140,"startTime":"0","endTime":"0","summary":"NEW YORK, March 01, 2024 (GLOBE NEWSWIRE) -- Kuehn Law, PLLC, a shareholder litigation law firm, is investigating potential claims related to the below-listed proposed mergers. Kuehn Law may seek addi","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.streetinsider.com/dr/news.php?id=22868942","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"highlight_streetinsider","symbols":["BK4007","BK4150","BK4535","BK4139","EVRI","SCTL","ISBC","BK4211","BK4539","FIXX","GRPH"],"gpt_icon":0},{"id":"2409463923","title":"SYM, VRNS and RVMD are among after hour movers","url":"https://stock-news.laohu8.com/highlight/detail?id=2409463923","media":"seekingalpha","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2409463923?lang=en_us&edition=fundamental","pubTime":"2024-02-06 05:55","pubTimestamp":1707170117,"startTime":"0","endTime":"0","summary":"Gainers:Semper Paratus Acquisition (LGST) +13%.Graphite (GRPH) +12%.Varonis Systems (VRNS) +8%.NXP Semiconductors (NXPI) +3%.Spruce Biosciences (SPRB) +3%.Losers:Symbotic (SYM) -18%.Rambus (RMBS) -8%.Kimball Electronics (KE) -7%.Amkor Technology (AMKR) -6%.Revolution Medicines (RVMD) -4%.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://seekingalpha.com/news/4062906-sym-vrns-and-rvmd-are-among-after-hour-movers","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"seekingalpha_hot_news","symbols":["LU1992135472.HKD","SYM","NXPI","BK4588","SPRB","LU0289960550.SGD","LU1923622291.USD","BK4561","LU2125909916.SGD","BK4147","BK4139","BK4145","LU1823568750.SGD","LU2272731782.SGD","BK4512","LU1992135399.USD","BK4141","LU2272731600.USD","LU0175139822.USD","LGST","RMBS","BK4097","LU1718418525.SGD","GRPH","BK4585","LU2133065610.SGD","LU1046421795.USD","BK4161","KE","VRNS","RVMD","AMKR","LU2125909759.SGD","BK4539"],"gpt_icon":0}],"profile":{"websiteUrl":"http://graphitebio.com","stockEarnings":[{"period":"1week","weight":-0.3239},{"period":"1month","weight":-0.3239},{"period":"3month","weight":-0.3239},{"period":"6month","weight":-0.3239},{"period":"1year","weight":-0.1004},{"period":"ytd","weight":-0.1794}],"compareEarnings":[{"period":"1week","weight":-0.0049},{"period":"1month","weight":0.0097},{"period":"3month","weight":0.0548},{"period":"6month","weight":0.1005},{"period":"1year","weight":0.2695},{"period":"ytd","weight":0.2651}],"compareStock":{"symbol":"SPY","name":"SPDR S&P 500 ETF Trust"},"description":"Graphite Bio, Inc., a clinical-stage gene editing company, engages in developing therapies for serious and life-threatening diseases in the United States. The company offers GPH102 for the treatment of beta-thalassemia; and GPH201 for the treatment of XSCID, a life-threatening disease for multiple mutations in a single gene. It also offers GPH301, a product candidate for the treatment of Gaucher disease, a genetic disorder that results in a deficiency in the glucocerebrosidase enzyme. The company was formerly known as Integral Medicines, Inc., and changed its name to Graphite Bio, Inc. in August 2020. Graphite Bio, Inc. was incorporated in 2017 and is based in South San Francisco, California.","exchange":"NASDAQ","name":"Graphite Bio, Inc.","nameEN":"Graphite Bio, Inc."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.29.4","shortVersion":"4.29.4","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Graphite Bio, Inc.(GRPH),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","description":"Find the latest Graphite Bio, Inc.(GRPH) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","keywords":"Graphite Bio, Inc.,GRPH,Graphite Bio, Inc.股票,Graphite Bio, Inc.股票老虎,Graphite Bio, Inc.股票老虎国际,Graphite Bio, Inc.行情,Graphite Bio, Inc.股票行情,Graphite Bio, Inc.股价,Graphite Bio, Inc.股市,Graphite Bio, Inc.股票价格,Graphite Bio, Inc.股票交易,Graphite Bio, Inc.股票购买,Graphite Bio, Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Graphite Bio, Inc.(GRPH),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","og_description":"Find the latest Graphite Bio, Inc.(GRPH) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","og_image":"https://community-static.tradeup.com/news/9b6dafd60190235ae8e2c95f52c583a0"}}}